» Articles » PMID: 20538807

Megakaryocytes Constitute a Functional Component of a Plasma Cell Niche in the Bone Marrow

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Jun 12
PMID 20538807
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Long-lived plasma cells in the bone marrow produce memory antibodies that provide immune protection persisting for decades after infection or vaccination but can also contribute to autoimmune and allergic diseases. However, the composition of the microenvironmental niches that are important for the generation and maintenance of these cells is only poorly understood. Here, we demonstrate that, within the bone marrow, plasma cells interact with the platelet precursors (megakaryocytes), which produce the prominent plasma cell survival factors APRIL (a proliferation-inducing ligand) and IL-6 (interleukin-6). Accordingly, reduced numbers of immature and mature plasma cells are found in the bone marrow of mice deficient for the thrombopoietin receptor (c-mpl) that show impaired megakaryopoiesis. After immunization, accumulation of antigen-specific plasma cells in the bone marrow is disturbed in these mice. Vice versa, injection of thrombopoietin allows the accumulation and persistence of a larger number of plasma cells generated in the course of a specific immune response in wild-type mice. These results demonstrate that megakaryocytes constitute an important component of the niche for long-lived plasma cells in the bone marrow.

Citing Articles

Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus.

Alzamareh D, Meednu N, Nandedkar-Kulkarni N, Krenitsky D, Barnard J, Yasaka K Front Immunol. 2025; 15:1499551.

PMID: 39867907 PMC: 11757124. DOI: 10.3389/fimmu.2024.1499551.


System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.

Cortese M, Hagan T, Rouphael N, Wu S, Xie X, Kazmin D Nat Immunol. 2025; 26(1):116-130.

PMID: 39747435 DOI: 10.1038/s41590-024-02036-z.


Contribution of long-lived plasma cells to antibody-mediated allograft rejection.

Jang E, Youn J Clin Transplant Res. 2024; 38(4):341-353.

PMID: 39690904 PMC: 11732765. DOI: 10.4285/ctr.24.0047.


Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow.

Lykins J, Becker I, Camacho V, Alfar H, Park J, Italiano J Blood Adv. 2024; 9(1):15-28.

PMID: 38941534 PMC: 11732581. DOI: 10.1182/bloodadvances.2024012995.


Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics.

Poveda-Garavito N, Combita A Front Immunol. 2024; 14:1325255.

PMID: 38299154 PMC: 10827891. DOI: 10.3389/fimmu.2023.1325255.